Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C274937-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $149.90 | |
C274937-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $599.90 | |
C274937-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,119.90 |
Potent NMDA antagonist
Synonyms | (R)-4-(3-phosphonopropyl)piperazine-2-carboxylic acid | (2R)-4-(3-phosphonopropyl)piperazine-2-carboxylic acid |
---|---|
Specifications & Purity | ≥95% |
Biochemical and Physiological Mechanisms | Highly potent, competitive NMDA antagonist; more active enantiomer of ( RS )-CPP . (K i values are 0.04 (NR1/NR2A), 0.3 (NR1/NR2B), 0.6 (NR1/NR2C) and 2.0 μM (NR1/NR2D)). |
Storage Temp | Store at -20°C,Desiccated |
Shipped In | Ice chest + Ice pads |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | (2R)-4-(3-phosphonopropyl)piperazine-2-carboxylic acid |
---|---|
INCHI | InChI=1S/C8H17N2O5P/c11-8(12)7-6-10(4-2-9-7)3-1-5-16(13,14)15/h7,9H,1-6H2,(H,11,12)(H2,13,14,15)/t7-/m1/s1 |
InChi Key | CUVGUPIVTLGRGI-SSDOTTSWSA-N |
Canonical SMILES | C1CN(CC(N1)C(=O)O)CCCP(=O)(O)O |
Isomeric SMILES | C1CN(C[C@@H](N1)C(=O)O)CCCP(=O)(O)O |
PubChem CID | 6603754 |
Molecular Weight | 252.21 |
Enter Lot Number to search for COA:
Solubility | Soluble in water to 100 mM |
---|
Starting at $543.90
Starting at $179.90
Starting at $138.90
Starting at $168.90
Starting at $109.90
Starting at $499.90
Starting at $183.90
Starting at $484.90
Starting at $59.90
Starting at $82.90
Starting at $131.90
Starting at $88.90
Starting at $105.90
Starting at $177.90
Starting at $117.90
1. Belhassen B & Motté G. (1979) [Intranodal reciprocal dual rhythm].. Arch Mal Coeur Vaiss, 72 (12): (1395-401). [PMID:120159] |
2. Hedrick T & Waters J. (2015) Acetylcholine excites neocortical pyramidal neurons via nicotinic receptors.. J Neurophysiol, 113 (7): (2195-209). [PMID:25589590] |
3. Pugh JR & Jahr CE. (2013) Activation of axonal receptors by GABA spillover increases somatic firing.. J Neurosci, 33 (43): (16924-9). [PMID:24155298] |
4. Pugh JR & Jahr CE. (2011) Axonal GABAA receptors increase cerebellar granule cell excitability and synaptic activity.. J Neurosci, 31 (2): (565-74). [PMID:21228165] |
5. Turecek J & Regehr WG. (2020) Cerebellar and vestibular nuclear synapses in the inferior olive have distinct release kinetics and neurotransmitters.. Elife, 9 [PMID:33259288] |
6. Rudolph S et al.. (2020) Cerebellum-Specific Deletion of the GABAA Receptor d Subunit Leads to Sex-Specific Disruption of Behavior.. Cell Rep, 33 (5): (108338). [PMID:33147470] |
7. Herman MA et al.. (2011) Distribution of extracellular glutamate in the neuropil of hippocampus.. PLoS One, 6 (11): (e26501). [PMID:22069455] |
8. Chanda S & Xu-Friedman MA. (2011) Excitatory modulation in the cochlear nucleus through group I metabotropic glutamate receptor activation.. J Neurosci, 31 (20): (7450-5). [PMID:21593328] |
9. Bagnall MW et al.. (2009) Glycinergic projection neurons of the cerebellum.. J Neurosci, 29 (32): (10104-10). [PMID:19675244] |
10. Balmer TS et al.. (2021) Incomplete removal of extracellular glutamate controls synaptic transmission and integration at a cerebellar synapse.. Elife, 10 [PMID:33616036] |
11. Winland CD et al.. (2017) Inflammation alters AMPA-stimulated calcium responses in dorsal striatal D2 but not D1 spiny projection neurons.. Eur J Neurosci, 46 (9): (2519-2533). [PMID:28921719] |
12. Qi Y et al.. (2014) Longitudinal testing of hippocampal plasticity reveals the onset and maintenance of endogenous human Aß-induced synaptic dysfunction in individual freely behaving pre-plaque transgenic rats: rapid reversal by anti-Aß agents.. Acta Neuropathol Commun, 2 (175). [PMID:25540024] |
13. Khan MM & Regehr WG. (2020) Loss of Doc2b does not influence transmission at Purkinje cell to deep nuclei synapses under physiological conditions.. Elife, 9 [PMID:32347796] |
14. Young MB & Thomas SA. (2014) M1-muscarinic receptors promote fear memory consolidation via phospholipase C and the M-current.. J Neurosci, 34 (5): (1570-8). [PMID:24478341] |
15. Vaden RJ et al.. (2020) Parvalbumin interneurons provide spillover to newborn and mature dentate granule cells.. Elife, 9 [PMID:32602839] |
16. Babola TA et al.. (2021) Purinergic Signaling Controls Spontaneous Activity in the Auditory System throughout Early Development.. J Neurosci, 41 (4): (594-612). [PMID:33303678] |
17. Guo C et al.. (2021) Purkinje cell outputs selectively inhibit a subset of unipolar brush cells in the input layer of the cerebellar cortex.. Elife, 10 [PMID:34369877] |
18. Apostolides PF & Trussell LO. (2013) Rapid, activity-independent turnover of vesicular transmitter content at a mixed glycine/GABA synapse.. J Neurosci, 33 (11): (4768-81). [PMID:23486948] |
19. Tang ZQ & Trussell LO. (2015) Serotonergic regulation of excitability of principal cells of the dorsal cochlear nucleus.. J Neurosci, 35 (11): (4540-51). [PMID:25788672] |
20. Burke DA & Alvarez VA. (2022) Serotonin receptors contribute to dopamine depression of lateral inhibition in the nucleus accumbens.. Cell Rep, 39 (6): (110795). [PMID:35545050] |
21. Bock R et al.. (2013) Strengthening the accumbal indirect pathway promotes resilience to compulsive cocaine use.. Nat Neurosci, 16 (5): (632-8). [PMID:23542690] |